title: [The effect of the angiotensin-converting enzyme inhibitor Capoten on the volume-regulation indices of patients with stage-II hypertension].
authors.forename: I K
authors.initials: IK
authors.lastname: Vladkovs'kyĭ
authors.forename: I A
authors.initials: IA
authors.lastname: Plesh
authors.forename: V A
authors.initials: VA
authors.lastname: Haĭdukov
authors.forename: M I
authors.initials: MI
authors.lastname: Loboda
mesh_terms: D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001810:Blood Volume / Q000187:drug effects*; D002216:Captopril / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009318:Natriuresis / Q000187:drug effects; D013997:Time Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002216:Captopril